Back to feed
TSHATaysha Gene Therapies, Inc.
CIK 0001806310 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Institution-led2/5 sources
18/100
Recent disclosures · timeline
- 8-K1.018.019.013d ago
Entry into a material agreement
Price · TSHA
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
TSHA corporate events · live SEC data- 1.018.019.01Material3d ago
Entry into a material agreement; Other events
Form 8-K — items reported: 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits.
Item 1.01 · Entry into a material agreement +2 moreView 8-K on EDGAR ↗
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data9 funds hold$292.92M reported valueNet accumulating(6 adding · 3 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 18,365,608 | $82.09M | 0.0% | Trim-1% |
| Vanguard Group Inc | 13,267,805 | $72.97M | 0.0% | Add+3% |
| FMR LLC (Fidelity) | 14,321,255 | $64.02M | 0.0% | Add |
Recent insider transactions
No insider transactions recorded for TSHA.